Issued Patents All Time
Showing 1–25 of 69 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12285397 | Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders | Brett Abrahams | 2025-04-29 |
| 12144801 | Methods and compositions for treatment of epileptic disorders | — | 2024-11-19 |
| 12109201 | Methods and compositions for treatment of epileptic disorders | — | 2024-10-08 |
| 11918563 | Methods and compositions for treatment of epileptic disorders | — | 2024-03-05 |
| 11918551 | Methods of treating seizure disorders and Prader-Willi syndrome | — | 2024-03-05 |
| 11903930 | Methods and compositions for treatment of epileptic disorders | — | 2024-02-20 |
| 11806336 | Methods and compositions for treatment of epileptic disorders | — | 2023-11-07 |
| 11771671 | Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, attention deficit hyperactivity disorder and addiction | — | 2023-10-03 |
| 11761006 | Use of MIR101 or MIR128 in the treatment of seizure disorders | — | 2023-09-19 |
| 11690829 | Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder | — | 2023-07-04 |
| 11660277 | Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders | Brett Abrahams | 2023-05-30 |
| 11395817 | Methods and compositions for treatment of epileptic disorders | — | 2022-07-26 |
| 11364228 | Gaboxadol for therapeutic treatment of 1p36 deletion syndrome | — | 2022-06-21 |
| 11291658 | Use of gaboxadol in the treatment of diabetes and related conditions | — | 2022-04-05 |
| 11278529 | Methods for treating aggression associated with Alzheimer's disease | — | 2022-03-22 |
| 11130952 | Use of MIR-92A or MIR-145 in the treatment of Angelman syndrome | — | 2021-09-28 |
| 11096929 | Methods of treating developmental disorders with gaboxadol | — | 2021-08-24 |
| 11090293 | Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering | — | 2021-08-17 |
| 10925879 | Methods of treating developmental disorders and/or seizure disorders with etifoxine | — | 2021-02-23 |
| 10870855 | Use of MIR101 or MIR128 in the treatment of seizure disorders | — | 2020-12-22 |
| 10813899 | Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related compounds, (1s,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders | Brett Abrahams | 2020-10-27 |
| 10813918 | Use of Gaboxadol in the treatment of diabetes and related conditions | — | 2020-10-27 |
| 10799485 | Methods and compositions for treatment of epileptic disorders | — | 2020-10-13 |
| 10765666 | Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering | — | 2020-09-08 |
| 10765646 | Methods of treating developmental encephalopathies | — | 2020-09-08 |